Suppr超能文献

Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.

作者信息

Manca-di-Villahermosa Simone, Taccone-Gallucci Massimo, Maccarrone Mauro

机构信息

Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy.

Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy.

出版信息

Kidney Int. 2009 Jun;75(12):1354-1355. doi: 10.1038/ki.2009.107.

Abstract
摘要

相似文献

3
[Statins in chronic renal disease].
Arq Bras Cardiol. 2005 Oct;85 Suppl 5:45-9. Epub 2006 Jan 2.
4
Nephroprotective and clinical potential of statins in dialyzed patients.
Expert Opin Ther Targets. 2009 May;13(5):541-50. doi: 10.1517/14728220902882130.
5
Statins for end-stage kidney disease treated with dialysis.
Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435.
6
Statins do not improve cardiovascular outcomes for dialysis patients.
Evid Based Med. 2014 Jun;19(3):89. doi: 10.1136/eb-2013-101606. Epub 2013 Dec 12.
7
HMG-CoA reductase inhibitors and the kidney.
Curr Hypertens Rep. 2005 Oct;7(5):337-42. doi: 10.1007/s11906-005-0066-4.
8
Rosuvastatin in patients undergoing hemodialysis.
N Engl J Med. 2009 Jul 2;361(1):93-4; author reply 94-5.
9
Statins in the prevention of cardiovascular events in patients with renal failure.
Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. doi: 10.2174/187152907780059119.
10
Rosuvastatin in patients undergoing hemodialysis.
N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验